Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Axonyx (AXYX)

Axonyx
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AXYX
DateTimeSourceHeadlineSymbolCompany
28/09/200621:15Business WireAxonyx Stockholders Approve Merger with TorreyPines Therapeutics Inc.NASDAQ:AXYXAxonyx
21/09/200616:00PR Newswire (US)TorreyPines Therapeutics to Present at the UBS Global Life Sciences ConferenceNASDAQ:AXYXAxonyx
30/08/200616:00PR Newswire (US)TorreyPines Therapeutics to Present at the Thomas Weisel Partners 2006 Healthcare ConferenceNASDAQ:AXYXAxonyx
08/08/200613:30Business WireAXONYX Inc. Announces Second Quarter 2006 Financial ResultsNASDAQ:AXYXAxonyx
07/08/200614:30PR Newswire (US)TorreyPines Therapeutics Initiates Phase I Clinical Trial of NGX426, a Novel Oral Therapy for Migraine and Neuropathic PainNASDAQ:AXYXAxonyx
04/08/200621:30Business WireAxonyx Receives Notice Related to Nasdaq Minimum Bid Price RuleNASDAQ:AXYXAxonyx
24/07/200614:30PR Newswire (US)TorreyPines Therapeutics Completes Second Phase I Study for NGX267, a Selective M1 Agonist for the Treatment of Alzheimer's DisNASDAQ:AXYXAxonyx
20/06/200616:00PR Newswire (US)TorreyPines Therapeutics to Present at the Jefferies & Company Life Sciences ConferenceNASDAQ:AXYXAxonyx
09/06/200616:34PR Newswire (US)TorreyPines Therapeutics to Present at the 2006 Pacific Growth Equities Life Sciences Growth ConferenceNASDAQ:AXYXAxonyx
08/06/200613:00Business WireAxonyx and TorreyPines to Host Webcast and Conference Call on Announced MergerNASDAQ:AXYXAxonyx
08/06/200611:30Business WireAxonyx and TorreyPines Therapeutics Announce Merger Agreement; Transaction Creates Robust Portfolio in the CNS Disease AreaNASDAQ:AXYXAxonyx
15/05/200621:15Business WireAxonyx Announces Completion of the Multiple-Dose Phase I Study of Posiphen(TM)NASDAQ:AXYXAxonyx
10/05/200622:30Business WireAxonyx Inc. Reports First Quarter 2006 Financial ResultsNASDAQ:AXYXAxonyx
09/05/200614:28Business WireAxonyx to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference; Presentation to be Web Cast Live on CorporatNASDAQ:AXYXAxonyx
24/04/200613:30Business WireResearcher Reports Data on Effects of Posiphen(TM) on Human Neuronal Stem Cells; Posiphen May Support Stem Cell TransplantationNASDAQ:AXYXAxonyx
20/04/200621:30Business WireAxonyx Reports Data on Effects of Phenserine on the Brains of Alzheimer's Disease Patients; PET Scans Show Increased Brain NeurNASDAQ:AXYXAxonyx
19/04/200621:30Business WireAxonyx Reports Data on Stabilized Brain Volumes in Alzheimer's Disease Patients Treated with Phenserine; Analysis of Brain ScanNASDAQ:AXYXAxonyx
16/03/200621:15Business WireAxonyx Reports Fourth Quarter and Full Year 2005 Financial ResultsNASDAQ:AXYXAxonyx
08/03/200621:24Business WireAxonyx Regains Compliance with Nasdaq Minimum Bid Price RuleNASDAQ:AXYXAxonyx
23/02/200613:33Business WireAxonyx to Present at the Wall Street Analyst Forum; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
14/02/200613:33Business WireAxonyx Reports Phenserine Associated with Significant Amyloid Reduction in Phase I Trial; Results Support Dual Mechanisms of ActNASDAQ:AXYXAxonyx
07/02/200614:00Business WireAxonyx to Present at BIO CEO & Investor Conference 2006; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
31/01/200613:30Business WireAxonyx Announces Acceptance of Four Abstracts Highlighting Phenserine and Posiphen by the 9th International Geneva/Springfield SNASDAQ:AXYXAxonyx
24/01/200613:30Business WireAxonyx Completes First Phase I Trial with Posiphen for Alzheimer's Disease ProgressionNASDAQ:AXYXAxonyx
04/01/200613:30Business WireAxonyx Announces License of Phenserine to Daewoong Pharmaceutical Company for South KoreaNASDAQ:AXYXAxonyx
09/11/200513:30Business WireAxonyx Inc. Announces Third Quarter Financial ResultsNASDAQ:AXYXAxonyx
07/11/200521:47Business WireAxonyx Provides Update on Clinical Development Program and Strategic InitiativesNASDAQ:AXYXAxonyx
26/10/200513:00Business WireAxonyx to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference; Presentation to Be Web Cast Live on Corporate WNASDAQ:AXYXAxonyx
20/09/200514:00Business WireAxonyx Announces Results of Curtailed Phase III Clinical Trials for Phenserine in Alzheimer's DiseaseNASDAQ:AXYXAxonyx
15/09/200513:30Business WireAxonyx to Present at the UBS 2005 Global Life Sciences Conference; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
 Showing the most relevant articles for your search:NASDAQ:AXYX